mebikar has been researched along with ofloxacin in 1 studies
| Studies (mebikar) | Trials (mebikar) | Recent Studies (post-2010) (mebikar) | Studies (ofloxacin) | Trials (ofloxacin) | Recent Studies (post-2010) (ofloxacin) |
|---|---|---|---|---|---|
| 61 | 17 | 23 | 6,484 | 976 | 1,346 |
| Protein | Taxonomy | mebikar (IC50) | ofloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit A | Escherichia coli K-12 | 1.5 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurnosova, NV; Kuz'menko, AV; Kuz'menko, VV | 1 |
1 other study(ies) available for mebikar and ofloxacin
| Article | Year |
|---|---|
[Correction of psychoemotional status in patients with chronic bacterial prostatitis].
Topics: Adult; Anti-Anxiety Agents; Anti-Infective Agents, Urinary; Biureas; Drug Therapy, Combination; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult | 2012 |